Vaccine

LeadingAge’s president and CEO has asked Congress to ensure access to COVID-19 tests, vaccines and treatments in letters supporting the White House’s request for COVID-19 supplemental funds.

CDC to update NHSN vaccine reporting requirements for nursing homes … Paxlovid “rebound” anecdotes concern patients, providers … Nasogastric tube feeding raises odds of pneumonia in advanced dementia...

Fourth COVID-19 vaccine dose boosts antibodies fivefold in Israeli study … ICUs may be spared omicron surge, investigation finds … New anemia drug for kidney dialysis patients may be approved in 2022...

The vaccine is less able to prevent infection, but retains 70% protection against hospitalization, a new study shows. The news comes as federal health officials warn that omicron is spreading rapidly in...

Sixteen participants with early, symptomatic Alzheimer’s will receive doses of a vaccine containing the immune-modulating drug Protollin. Nasal delivery has shown promise as a way to eliminate beta amyloid...

A second shot of Johnson & Johnson’s vaccine provides 100% protection against severe or critical COVID-19 when given two months after a first dose, according to new data.

A vaccine candidate developed to protect vulnerable adults against the common respiratory syncytial virus has shown 80% efficacy in reducing the risk of dangerous lower respiratory tract diseases such...

A 50-microgram dose appears to be effective enough to increase waning vaccine protection, and may reduce the risk of side effects, sources tell investigators.

New data from vaccine maker Pfizer and Israel’s health ministry may help U.S. health agencies make a case for recommending COVID-19 booster shots, various sources report.

The benefits of the shot — including reduced hospitalization, intensive care unit admission and death — outweigh the risk of contracting Guillain-Barre syndrome, the Advisory Committee on Immunization...